Since both AKR1C3 and AKR1B10 were elevated in liver tumor tissues 50, an interplay between AKR1B10 and AKR1C3 by balancing FAO and glycolysis might be required to adapt to differential tumor environments and metabolic demands. This evidence concerns the gene AKR1B10 and neoplasm.